Endpoint News BET Inhibitors

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Endpoint News BET Inhibitors

posted on Mar 27, 2018 08:21PM

Nice to see BET inhibitors (I-BET-762) getting coverage in news outlets like Endpoints. However, this brief article only focused on recently published preclinical research and hardly acknowledged the various clinical trials ongoing or the many companies with BET programs.

https://endpts.com/preclinical-study-shines-lights-on-bet-inhibitors-potential-to-prevent-obesity-related-cancer-growth/

6 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply